SCHEMBL6844335

SCHEMBL6844335

CN(CCCCn1cnc(-c2ccccc2)c1-c1ccccc1)Cc1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 4/20 0.71
MAPK12 P53778 4/20 0.71
MAPK11 Q15759 4/20 0.71
MAPK14 Q16539 4/20 0.71
PRKD3 O94806 1/20 0.52
MAP4K4 O95819 1/20 0.52
FRK P42685 1/20 0.52
MAPK9 P45984 1/20 0.52
CSNK1A1 P48729 1/20 0.52
CSNK1D P48730 1/20 0.52
GSK3B P49841 1/20 0.52
PRKD2 Q9BZL6 1/20 0.52
MAP4K5 Q9Y4K4 1/20 0.52
MAOB P27338 3/20 0.48
ACHE P22303 5/20 0.47
SIGMAR1 Q99720 1/20 0.47
PTGS2 P35354 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6847077 0.99 MAPK13 (0.70) MAPK13MAPK12MAPK11MAPK14PRKD3
SCHEMBL6846961 0.96 MAPK13 (0.76) MAPK13MAPK12MAPK11MAPK14PRKD3
SCHEMBL6844081 0.88 MAPK13 (0.56) MAPK13MAPK12MAPK11MAPK14PRKD3
SCHEMBL6847084 0.87 MAPK13 (0.55) MAPK13MAPK12MAPK11MAPK14PRKD3
SCHEMBL6846914 0.86 MAPK13 (0.55) MAPK13MAPK12MAPK11MAPK14PRKD3
SCHEMBL6592909 0.85 MAP4K4 (0.58) MAPK13MAPK12MAPK11MAPK14PRKD3
SCHEMBL6844395 0.85 MAPK13 (0.54) MAPK13MAPK12MAPK11MAPK14PRKD3
SCHEMBL6591428 0.84 MAP4K4 (0.56) MAPK13MAPK12MAPK11MAPK14PRKD3
SCHEMBL6839498 0.84 MAPK13 (0.60) MAPK13MAPK12MAPK11MAPK14PRKD3
SCHEMBL4915616 0.84 MAPK14 (1.00) MAPK13MAPK12MAPK11MAPK14PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040162328-A1 Compounds of the family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents L'OREAL (FR) 2004-08-19 US claimed
US-20040162328-A1 Compounds of the family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents L'OREAL (FR) 2004-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162328-A1 Compounds of the family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents TRPV1, TRPA1, TRPV3 MAPK13 3380/4885MAPK12 3724/4885MAPK11 3516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.